Neutral
Regeneron Pharmaceuticals (NASDAQ:REGN) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen has downgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "Buy" to a "Hold" rating. Despite this downgrade, other analysts collect...